Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01857869
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:15.342098+00:00
Published At
2018-12-26T00:00:00+00:00
Record Updated At
2019-06-26
Results Posted At
2018-12-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Malaria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-06-26"
protocolSection.identificationModule.nctId
"NCT01857869"
protocolSection.identificationModule.officialTitle
"Efficacy, Safety and Immunogenicity Study of GSK Biologicals\u0027 Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-na\u00efve Adults"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-12-26"

Study condition terms

  • Malaria (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.